SARS COV‐2 INFECTION IN A DIABETES TYPE 1 PATIENT ON CGM: A CASE REPORT
Danijel Đekić*, Goran Topić*, Milena Brkić, Jasminka Radosavac and Vlado Đajić
ABSTRACT
Patients with type 1 diabetes belong to the risk group of patients with COVID 19 infection. Hyperglycemia during hospitalization for COVID- 19 has also been established as a poor prognostic indicator. Some studies report that those with previously poorly controlled diabetes tend to have higher morbidity and mortality. Here we present a patient with type 1 diabetes who was admitted to the intensive care unit with signs of pneumonia and ketoacidosis. We also wanted to show the benefits of CGM in the treatment of such patients due to the titration of insulin therapy and to indicate the reduction of the risk of exposure of medical workers when working in a COVID environment.
[Full Text Article] [Download Certificate]